Chemours (CC) Revenue (2014 - 2026)

Chemours has reported Revenue for 13 years, with the latest figure at $1.6 billion in Q2 2026.

• On a quarterly basis, Revenue fell 1.49% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $5.8 billion, a 0.92% decrease from a year earlier, with the FY2025 full-year figure at $5.8 billion, changed 0.45% from the prior year.
• Revenue was $1.6 billion for Q2 2026 at Chemours, up from $1.4 billion in the prior quarter.
• The five-year high for Revenue was $1.9 billion in Q2 2022, with the low at $1.3 billion in Q4 2025.
• Average Revenue over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue gained 22.84% in 2022, then decreased 15.53% in 2023.
• Over 5 years, Revenue stood at $1.3 billion in 2022, then grew by 2.24% to $1.4 billion in 2023, then decreased by 0.66% to $1.4 billion in 2024, then decreased by 2.21% to $1.3 billion in 2025, then gained by 19.71% to $1.6 billion in 2026.
• The last three Revenue figures came in at $1.6 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.